Sex differences in HIV infection

EP Scully - Current HIV/AIDS Reports, 2018 - Springer
Abstract Purpose of Review This review will outline the multilevel effects of biological sex on
HIV acquisition, pathogenesis, treatment response, and prospects for cure. Potential …

Total HIV-1 DNA, a marker of viral reservoir dynamics with clinical implications

V Avettand-Fènoël, L Hocqueloux… - Clinical microbiology …, 2016 - Am Soc Microbiol
SUMMARY HIV-1 DNA persists in infected cells despite combined antiretroviral therapy
(cART), forming viral reservoirs. Recent trials of strategies targeting latent HIV reservoirs …

Persistent low-level viremia in persons living with HIV undertreatment: an unresolved status

C Crespo-Bermejo, ER de Arellano, V Lara-Aguilar… - Virulence, 2021 - Taylor & Francis
Antiretroviral therapy (ART) allows suppressed viremia to reach less than 50 copies/mL in
most treated persons living with HIV (PLWH). However, the existence of PLWH that show …

Sex-based differences in human immunodeficiency virus type 1 reservoir activity and residual immune activation

EP Scully, M Gandhi, R Johnston, R Hoh… - The Journal of …, 2019 - academic.oup.com
Plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in women are lower early
in untreated HIV-1 infection compared with those in men, but women have higher T-cell …

Sex differences in human immunodeficiency virus persistence and reservoir size during aging

S Gianella, SA Rawlings, C Dobrowolski… - Clinical Infectious …, 2022 - academic.oup.com
Background Sex differences in human immunodeficiency virus (HIV) reservoir dynamics
remain underexplored. Methods Longitudinal samples from virally suppressed midlife …

Advances and perspectives in the use of carbon nanotubes in vaccine development

EN de Carvalho Lima, RS Diaz, JF Justo… - International Journal …, 2021 - Taylor & Francis
Advances in nanobiotechnology have allowed the utilization of nanotechnology through
nanovaccines. Nanovaccines are powerful tools for enhancing the immunogenicity of a …

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

C Katlama, S Lambert-Niclot, L Assoumou, L Papagno… - Aids, 2016 - journals.lww.com
Background: As a first step towards HIV cure, we assessed a strategy of antiretroviral
therapy (ART) intensification followed by interleukin-7 (IL-7) used as an HIV-reactivating …

Evaluation of archival HIV DNA in brain and lymphoid tissues

MF Oliveira, A Pankow, T Vollbrecht, NM Kumar… - Journal of …, 2023 - Am Soc Microbiol
ABSTRACT HIV reservoirs persist in anatomic compartments despite antiretroviral therapy
(ART). Characterizing archival HIV DNA in the central nervous system (CNS) and other …

[HTML][HTML] Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, Uganda

JL Prodger, AA Capoferri, K Yu, J Lai, SJ Reynolds… - JCI insight, 2020 - ncbi.nlm.nih.gov
HIV-1 infection remains incurable owing to the persistence of a viral reservoir that harbors
integrated provirus within host cellular DNA. Increasing evidence links sex-based …

Sex differences in primary HIV infection: revisiting the role of TLR7-driven type 1 IFN production by plasmacytoid dendritic cells in women

JC Guéry - Frontiers in Immunology, 2021 - frontiersin.org
Plasmacytoid dendritic cells (pDCs) produce type I interferon (IFN-I) during HIV-1 infection in
response to TLR7 stimulation. However, IFN-I-signaling has been shown to play opposite …